| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 511* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 508* | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 325 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 252 | 2022 |
| Immunomodulatory drugs in the management of SARS-CoV-2 DR Burrage, S Koushesh, N Sofat Frontiers in immunology 11, 1844, 2020 | 87 | 2020 |
| The ‘top 100’drugs and classes in England: an updated ‘starter formulary’for trainee prescribers S Audi, DR Burrage, DO Lonsdale, S Pontefract, JJ Coleman, ... British journal of clinical pharmacology 84 (11), 2562-2571, 2018 | 62 | 2018 |
| The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy EF Magavern, JC Kaski, RM Turner, H Drexel, A Janmohamed, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (1), 85-99, 2022 | 38 | 2022 |
| The top 100 drugs: clinical pharmacology and practical prescribing AW Hitchings, D Lonsdale, D Burrage, E Baker Elsevier Health Sciences, 2018 | 30 | 2018 |
| Contributions of cardiovascular risk and smoking to chronic obstructive pulmonary disease (COPD)-related changes in brain structure and function CA Spilling, MPK Bajaj, DR Burrage, S Ruickbie, NJ Thai, EH Baker, ... International journal of chronic obstructive pulmonary disease, 1855-1866, 2019 | 26 | 2019 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 24 | 2023 |
| COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure MPK Bajaj, DR Burrage, A Tappouni, JW Dodd, PW Jones, EH Baker Clinical interventions in aging, 1-8, 2019 | 16 | 2019 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 15 | 2023 |
| Nitrous oxide‐induced neurotoxicity: A case report and literature review D Thayabaran, D Burrage British Journal of Clinical Pharmacology 87 (9), 3622-3626, 2021 | 15 | 2021 |
| Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD) GJ McKay, RV McCarter, RE Hogg, DH Higbee, MPK Bajaj, DR Burrage, ... PloS one 15 (1), e0227175, 2020 | 8 | 2020 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 7 | 2024 |
| Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy EF Magavern, JC Kaski, RM Turner, H Drexel, A Janmohamed, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (1), 100-103, 2022 | 6 | 2022 |
| Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease CA Spilling, MPK Dhillon, DR Burrage, S Ruickbie, EH Baker, TR Barrick, ... Plos one 16 (11), e0259375, 2021 | 3 | 2021 |
| Prescribing for elderly people DR Burrage, EV Lonsdale, DO Lonsdale, E Baker British Journal of Hospital Medicine 75 (Sup8), C119-C121, 2014 | 3 | 2014 |
| The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular … EF Magavern, JC Kaski, RM Turner, H Drexel, A Janmohamed, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (1), 116-116, 2022 | 2 | 2022 |
| Retinal microvascular changes in people with COPD compared to age-matched smokers without COPD GJ McKay, R McCarter, RE Hogg, MPK Bajaj, D Burrage, S Ruickbie, ... A14. COPD: SYSTEMS BIOLOGY AND COMORBIDITY, A1012-A1012, 2017 | 2 | 2017 |
